StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories diagnostics Segment Total — Reported Sales Growth (%) (%)

Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A

QuarterlyAnnual
Latest, Q3 2026
46.7%
Period ended Sep 30, 2026
Change on a year earlier
+53.3 pts
-6.6% in Q3 2025
History
44 quarters
Since Q4 2015
Sources
44
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiagnostics Segment Total — Reported Sales Growth (%) (%)Year on yearSource
Q3 2026Sep 30, 202646.7%+53.3 ptsSEC Filing (0001628280-26-066601) ↗
Q2 2026Jun 30, 202642.3%+43.3 ptsSEC Filing (0001628280-26-048377) ↗
Q1 2026Mar 31, 20266.1%+13.3 ptsSEC Filing (0001628280-26-025365) ↗
Q4 2025Dec 31, 2025-2.5%-1.9 ptsSEC Filing (0001628280-26-002982) ↗
Q3 2025Sep 30, 2025-6.6%-5.1 ptsSEC Filing (0001628280-25-045049) ↗
Q2 2025Jun 30, 2025-1.0%+4.3 ptsSEC Filing (0001628280-25-035135) ↗
Q1 2025Mar 31, 2025-7.2%+10.4 ptsSEC Filing (0001628280-25-017924) ↗
Q4 2024Dec 31, 2024-0.6%+22.1 ptsSEC Filing (0001628280-25-002092) ↗
Q3 2024Sep 30, 2024-1.5%+31.2 ptsSEC Filing (0001628280-24-042893) ↗
Q2 2024Jun 30, 2024-5.3%+40.7 ptsSEC Filing (0001628280-24-032182) ↗
Q1 2024Mar 31, 2024-17.6%+31.3 ptsSEC Filing (0001628280-24-016497) ↗
Q4 2023Dec 31, 2023-22.7%+3.4 ptsSEC Filing (0001628280-24-002009) ↗
Q3 2023Sep 30, 2023-32.7%-26.5 ptsSEC Filing (0001628280-23-034544) ↗
Q2 2023Jun 30, 2023-46.0%-48.5 ptsSEC Filing (0001628280-23-025156) ↗
Q1 2023Mar 31, 2023-48.9%-56.3 ptsSEC Filing (0001628280-23-012020) ↗
Q4 2022Dec 31, 2022-26.1%-29.0 ptsSEC Filing (0001628280-23-001516) ↗

Cite this data

StockData. (2026). Abbott Laboratories Diagnostics Segment Total — Reported Sales Growth (%) (%), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/dx-tot-yoy-rep

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.